ganaxolone

Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Randomized Therapy In Status Epilepticus

Open-label Extension to Protocol 1042-0500

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Ganaxolone Expanded Access Program Compassionate Use

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

Ganaxolone Treatment in Children With Fragile X Syndrome

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Open-label Extension to Protocol 1042-0600

Ganaxolone in Posttraumatic Stress Disorder (PTSD)